Advertisement
Advertisement
SGHT
Sight Sciences, Inc. Common Stock
10.08
USDSponsored
+0.32
+3.28%
Nov 06, 15:59 UTC -5
Closed
After-Market
10.08
0.00
0.00%
Sight Sciences, Inc. Common Stock (SGHT) Earnings
SGHT Earnings Reports
Positive Surprise Ratio
SGHT beat 14 of 22 last estimates.
64%
Next Report
Date of Next Report
Mar 02, 2027
Estimate for Q4 26 (Revenue/ EPS)
$24.19M
/-$0.14
Implied change from Q3 26 (Revenue/ EPS)
-2.94%
/+16.67%
Implied change from Q4 25 (Revenue/ EPS)
+18.65%
/+75.00%
Sight Sciences, Inc. Common Stock earnings per share and revenue
On Nov 04, 2026, SGHT reported earnings of -0.12 USD per share (EPS) for Q3 26, beating the estimate of -0.13 USD, resulting in a 12.22% surprise. Revenue reached 24.92 million, compared to an expected 23.98 million, with a 3.91% difference. The market reacted with a +0.83% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of -0.14 USD, with revenue projected to reach 24.19 million USD, implying an increase of 16.67% EPS, and decrease of -2.94% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Tandem Diabetes Care, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.24
Actual
-$0.10
Surprise
+59.55%
Artivion, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.06
Actual
$0.08
Surprise
+228.00%
Mobia Medical, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.47
Actual
-$0.52
Surprise
-9.04%
Treace Medical Concepts, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.25
Actual
-$0.19
Surprise
+26.67%
Inogen Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.56
Surprise
-285.41%
Envoy Medical, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.68
Actual
-$0.50
Surprise
+26.47%
Mettler-Toledo International
Report Date
Nov 05, 2026 For Q3 26
Estimate
$12.21
Actual
$12.57
Surprise
+2.90%
GLOBUS MEDICAL INC
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.22
Actual
$1.23
Surprise
+0.75%
Teleflex Incorporated
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.92
Actual
$2.63
Surprise
+36.82%
CVRx, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.50
Actual
-$0.52
Surprise
-2.91%
FAQ
What were Sight Sciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Sight Sciences, Inc. Common Stock reported EPS of -$0.12, beating estimates by 12.22%, and revenue of $24.92M, 3.91% above expectations.
How did the market react to Sight Sciences, Inc. Common Stock's Q3 2026 earnings?
The stock price moved up 0.83%, changed from $9.68 before the earnings release to $9.76 the day after.
When is Sight Sciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 02, 2027.
What are the forecasts for Sight Sciences, Inc. Common Stock's next earnings report?
Based on --
analysts, Sight Sciences, Inc. Common Stock is expected to report EPS of -$0.14 and revenue of $24.19M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.